Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2021-09-23 00:00:00 ET · period of report 2021-09-21 · accession 0001770252-21-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-23 | 2021-09-21 | MYGN | Lambert Nicole | See Remarks | A - Grant | $0.00 | +65.9K | 192.9K | +52% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-21 | A | A | 65,870 | $0.00 | 192,921 | D | — | — |